Targeted radionuclide therapy in patient-derived xenografts using (177)Lu-EB-RGD

Currently, most patients with non-small cell lung cancer (NSCLC) are diagnosed in advanced stages with a poor five-year survival rate. Therefore, intensive research aimed at finding novel therapeutic strategies has been ongoing; experimental models that reliably emulate NSCLC disease are greatly nee...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Mol Cancer Ther
Asıl Yazarlar: Zhao, Liang, Chen, Haojun, Guo, Zhide, Fu, Kaili, Yao, Lanling, Fu, Li, Guo, Weixi, Wen, Xuejun, Jacobson, Orit, Zhang, Xianzhong, Sun, Long, Wu, Hua, Lin, Qin, Chen, Xiaoyuan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7541553/
https://ncbi.nlm.nih.gov/pubmed/32847972
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-19-1098
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller